The Cybersecurity & Infrastructure Security Agency (CISA) is warning that hackers are exploiting a critical vulnerability in ...

Motex released urgent patches for a critical vulnerability in Lanscope Endpoint Manager that has been exploited in the wild as a zero-day.

(NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the ...

Justice Brett Kavanaugh questioned when the provision requiring race-based redistricting in the Voting Rights Act would ...

Moderna said its cytomegalovirus (CMV) vaccine didn't meet the primary efficacy endpoint in a Phase 3 trial, and it is discontinuing the clinical development program.

Novel combination including eftilagimod alfa (efti) in neoadjuvant setting drives 51.5% tumour hyalinization/fibrosis in patients with soft tissue sarcoma (pHigh level of tumour hyalinization/fibrosis ...

U.S. Marshals captured fugitive Kevin L. Brown in Clarksville, Tennessee, in connection with a Memphis shooting.

Shares of Neuphoria Therapeutics were trading in the red in the after-hours session Monday, as the company announced a strategic review following news BNC210 anti-anxiety drug didn't meet the primary ...

Topline results were announced from a phase 3 study evaluating Moderna’s cytomegalovirus (CMV) vaccine candidate, mRNA-1647.

The approval was based on the SOUL trial, which evaluated oral semaglutide in adults 50 years and older with T2DM and ...

Adam Pettit, CEO of the newly named Iru, explains how the company formerly known as Kandji manages Windows, Android and Apple ...

Topline results were announced from a phase 3 trial evaluating BNC210 in patients with social anxiety disorder.